Literature DB >> 35705696

Impaired glucocorticoid receptor expression and mitochondrial metabolism in MDSCs contribute to glucocorticoid resistance in immune thrombocytopenia.

Rick Kapur1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35705696      PMCID： PMC9242977          DOI： 10.1038/s41423-022-00880-3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   22.096


× No keyword cloud information.
  15 in total

1.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

2.  Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.

Authors:  L Guo; R Kapur; R Aslam; K Hunt; Y Hou; A Zufferey; E R Speck; M T Rondina; A H Lazarus; H Ni; J W Semple
Journal:  Scand J Immunol       Date:  2018-07       Impact factor: 3.487

3.  Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14++ CD16+ intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotype.

Authors:  Emily L Williams; Madeleine L Stimpson; Philippa J P Lait; Lauren P Schewitz-Bowers; Lauren V Jones; Ashwin D Dhanda; Richard W J Lee; Charlotte A Bradbury
Journal:  Br J Haematol       Date:  2020-12-18       Impact factor: 6.998

4.  The abnormal function of CD39+ regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia.

Authors:  Yumeng Lu; Luya Cheng; Feng Li; Lili Ji; Xia Shao; Boting Wu; Yanxia Zhan; Chanjuan Liu; Zhihui Min; Yang Ke; Lihua Sun; Hao Chen; Yunfeng Cheng
Journal:  Ann Hematol       Date:  2019-06-01       Impact factor: 3.673

5.  Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).

Authors:  Rick Kapur; Rukhsana Aslam; Edwin R Speck; Johan M Rebetz; John W Semple
Journal:  Platelets       Date:  2019-05-30       Impact factor: 3.862

6.  A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.

Authors:  Leola Chow; Rukhsana Aslam; Edwin R Speck; Michael Kim; Norman Cridland; Michelle Lee Webster; Pingguo Chen; Kim Sahib; Heyu Ni; Alan H Lazarus; M Bernadette Garvey; John Freedman; John W Semple
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

7.  High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.

Authors:  Yu Hou; Qi Feng; Miao Xu; Guo-Sheng Li; Xue-Na Liu; Zi Sheng; Hai Zhou; Ji Ma; Yu Wei; Yuan-Xin Sun; Ying-Yi Yu; Ji-Hua Qiu; Lin-Lin Shao; Xin-Guang Liu; Ming Hou; Jun Peng
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

8.  Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.

Authors:  Yun Ling; Xiangshan Cao; Ziqiang Yu; Changgeng Ruan
Journal:  Eur J Haematol       Date:  2007-08-10       Impact factor: 2.997

9.  American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Authors:  Cindy Neunert; Deirdra R Terrell; Donald M Arnold; George Buchanan; Douglas B Cines; Nichola Cooper; Adam Cuker; Jenny M Despotovic; James N George; Rachael F Grace; Thomas Kühne; David J Kuter; Wendy Lim; Keith R McCrae; Barbara Pruitt; Hayley Shimanek; Sara K Vesely
Journal:  Blood Adv       Date:  2019-12-10

Review 10.  Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia.

Authors:  Anne-Tess C Jolink; Vivianne S Nelson; Martin R Schipperus; Sufia N Amini; Gestur Vidarsson; C Ellen van der Schoot; Leendert Porcelijn; Masja de Haas; Rick Kapur
Journal:  J Clin Med       Date:  2021-07-30       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.